![Photo of Leonard Sacks against blue background.](https://public4.pagefreezer.com:443/content/FDA/10-05-2023T14:26/http://www.fda.gov/files/styles/medium_3/public/leonard-sacks-cder-conversation.png?itok=WfHFRMWT)
Expert discusses how clinical trials are adopting remote elements
May 2 - Conversation describes benefits, challenges of this phenomenon
May 2 - Conversation describes benefits, challenges of this phenomenon
May 1 - Event will address RDEA pilot program and issues with efficacy endpoints
May 1 - Unapproved products containing ammonia can be harmful
April 28 - The 2-day workshop will discuss researching and assessing nitrosamine risk in drugs
April 26 - Webinar will cover fee types, collection and payment process, and more
April 21 - Resources include trainings, stakeholder engagement, and more
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.